補助人工心臓市場規模、シェア、成長分析：製品タイプ別、フロータイプ別、地域別 - 産業予測、2024年～2031年

補助人工心臓の世界市場規模は、2022年に22億米ドルと評価され、2023年の24億米ドルから2031年には59億米ドルに成長し、予測期間中（2024-2031年）のCAGRは7.9％で成長する見通しです。

心血管系疾患の急増と心臓移植のニーズの高まりが、今後数年間の補助人工心臓（VADs）の売上を大きく押し上げると思われます。世界人口の急速な高齢化は、この救命装置の需要をさらに押し上げると思われます。新しい補助人工心臓の設計と機能性における革新は、研究開発への投資の増加とともに、この分野の企業にとって新たなビジネスチャンスをもたらすと期待されています。さらに、世界のヘルスケア支出の増加は、補助人工心臓メーカーの収益性を高める可能性が高いです。全人工心臓の受け入れと利用可能性の拡大も、予測期間とそれ以降の市場拡大を支えると思われます。しかし、補助人工心臓の高コスト、使用に伴う合併症の可能性、厳しい規制状況などの課題は、長期的には需要見通しを弱める可能性があります。全体として、市場は人口動向と技術の進歩によって力強い成長機会が見込まれるもの、利害関係者がこうした機会を十分に活用するには、財政的・規制的なハードルを乗り越えなければならないです。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要のトレンド分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 推進力と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 技術の進歩
• 規制情勢
• 特許分析
• バリューチェーン分析
• ケーススタディ分析
• PESTEL分析
• マクロ経済指標
• 貿易分析
• スタートアップ分析
• 原材料の分析
• サプライチェーン分析
• 価格分析

補助人工心臓市場：製品別

• 左心室補助装置
• 右心室補助装置
• 両心室補助装置
• 完全人工心臓

補助人工心臓市場：フロータイプ別

• 脈動フロー
• 連続フロー

補助人工心臓市場：用途別

• 心臓移植への橋渡し
• DT治療
• その他

補助人工心臓市場：デザイン別

• 市場概要：植込み型補助人工心臓
• 経皮的心室補助装置

補助人工心臓市場：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東およびアフリカ
  • アラブ首長国連諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• FineHeart SA
• TELEFLEX INCORPORATED
• BiVACOR
• Abbott
• Berlin Heart
• Cardiac Assist, Inc.
• Jarvik Heart, Inc.
• ReliantHeart, Inc.
• SYNCARDIA SYSTEMS
• FRESENIUS MEDICAL CARE AG & CO. KGAA
• GETINGE
• SENKO MEDICAL INSTRUMENT MFG. CO., LTD
• ANGIODROID
• CARDIODYME
• WORLD HEART CORPORATION
• Sun Medical Technology Research Corporation
• CorWave SA
• Windmill Cardiovascular Systems
• Leviticus Cardio
• CardioBridge GmbH

結論と推奨事項

Global Ventricular Assist Devices Market size was valued at USD 2.2 billion in 2022 and is poised to grow from USD 2.4 billion in 2023 to USD 5.9 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

The booming incidence of cardiovascular diseases, coupled with an escalating need for heart transplants, is set to significantly drive the sales of ventricular assist devices (VADs) in the coming years. The rapidly aging global population will further propel the demand for these life-saving devices. Innovations in the design and functionality of new VADs, alongside increased investments in research and development, are expected to unlock fresh opportunities for companies within this sector. Additionally, rising healthcare expenditures worldwide are likely to enhance revenue potential for VAD manufacturers. The growing acceptance and availability of total artificial hearts will also support market expansion throughout the forecast period and beyond. However, challenges such as the high cost of VADs, potential complications associated with their use, and a stringent regulatory landscape may temper the demand outlook in the long run. Overall, while the market presents robust growth prospects driven by demographic trends and technological advancements, stakeholders must navigate financial and regulatory hurdles to fully capitalize on these opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ventricular Assist Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ventricular Assist Devices Market Segmental Analysis

Global Ventricular Assist Devices Market is segmented by Product, Type of Flow, Design, Application, and region. Based on Product, the market is segmented into Left Ventricular Assist Device, Right Ventricular Assist Device, Bi-Ventricular Assist Device, Total Artificial Heart. Based on Type of Flow, the market is segmented into Pulsatile Flow, Continuous Flow. Based on Design, the market is Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device. Based on Application, the market is segmented into Bridge to Transplant, Destination Therapy, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Ventricular Assist Devices Market

The Global Ventricular Assist Devices market is significantly driven by the growing acceptance and awareness surrounding these devices in recent years. As patients increasingly recognize the advantages that ventricular assist devices offer, their willingness to embrace these innovative solutions for heart support is rising. This shift in perception is anticipated to contribute to robust market growth, as more individuals consider these devices as viable options to enhance their treatment outcomes and overall quality of life. Consequently, the demand for ventricular assist devices is expected to continue its upward trajectory, fueled by both medical advancements and patient education.

Restraints in the Global Ventricular Assist Devices Market

The Global Ventricular Assist Devices market faces significant restraints primarily due to limited access in developing regions. These sophisticated medical devices are typically utilized in intricate procedures like heart transplants or the implementation of artificial hearts. However, many developing countries lack the infrastructure and resources to offer such advanced treatments, which restricts the market's potential for growth and sales in these areas. As a result, the inability to provide adequate healthcare options hinders the widespread adoption and distribution of ventricular assist devices, ultimately impacting the overall market dynamics and opportunities for manufacturers and healthcare providers.

Market Trends of the Global Ventricular Assist Devices Market

The global ventricular assist devices market is witnessing a significant trend towards miniaturization, driven by the need for improved implantation versatility and patient outcomes. Companies are increasingly adopting innovative design technologies and materials to create smaller, more efficient devices. This shift not only enhances usability in a broader range of patient anatomies but also aligns with the growing demand for less invasive surgical options. As market players focus on developing compact solutions, enhanced portability and minimized complications are expected to boost sales and market share, positioning these companies favorably in an increasingly competitive landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Supply Chain Analysis
• Pricing Analysis

Global Ventricular Assist Devices Market Size by Product & CAGR (2024-2031)

• Left Ventricular Assist Device
• Right Ventricular Assist Device
• Bi-Ventricular Assist Device
• Total Artificial Heart

Global Ventricular Assist Devices Market Size by Type of Flow & CAGR (2024-2031)

• Pulsatile Flow
• Continuous Flow

Global Ventricular Assist Devices Market Size by Application & CAGR (2024-2031)

• Bridge to Transplant
• Destination Therapy
• Others

Global Ventricular Assist Devices Market Size by Design & CAGR (2024-2031)

• Market Overview Implantable Ventricular Assist Device
• Transcutaneous Ventricular Assist Device

Global Ventricular Assist Devices Market Size & CAGR (2024-2031)

• North America, (Product, Type of Flow, Application, Design)
  • US
  • Canada
• Europe, (Product, Type of Flow, Application, Design)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Type of Flow, Application, Design)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Type of Flow, Application, Design)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Type of Flow, Application, Design)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• FineHeart SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TELEFLEX INCORPORATED
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Assist, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReliantHeart, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYNCARDIA SYSTEMS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FRESENIUS MEDICAL CARE AG & CO. KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GETINGE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SENKO MEDICAL INSTRUMENT MFG. CO., LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANGIODROID
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARDIODYME
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WORLD HEART CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Medical Technology Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorWave SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Windmill Cardiovascular Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leviticus Cardio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioBridge GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation